2004
DOI: 10.1016/j.talanta.2004.05.032
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant cell bioassay systems for the detection and relative quantitation of halogenated dioxins and related chemicals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
96
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 91 publications
(98 citation statements)
references
References 95 publications
2
96
0
Order By: Relevance
“…Instrumental analysis does not account for interactions among the chemicals in complex mixtures and provides little information on their biological effects (Brack 2003;Rijk et al 2009). Therefore, the instrumental results are not well suited to predict the toxicity of unknown chemicals in the system, nor the complex interactions of known chemicals that could lead to additivity, antagonism, and synergism on biota (Villeneuve et al 2000;Denison et al 2004). Furthermore, chemicals that are biologically active at concentrations below the analytical detection limits are missed by instrumental analysis.…”
Section: Introductionmentioning
confidence: 99%
“…Instrumental analysis does not account for interactions among the chemicals in complex mixtures and provides little information on their biological effects (Brack 2003;Rijk et al 2009). Therefore, the instrumental results are not well suited to predict the toxicity of unknown chemicals in the system, nor the complex interactions of known chemicals that could lead to additivity, antagonism, and synergism on biota (Villeneuve et al 2000;Denison et al 2004). Furthermore, chemicals that are biologically active at concentrations below the analytical detection limits are missed by instrumental analysis.…”
Section: Introductionmentioning
confidence: 99%
“…More recently, the use of in vitro bioassays based on AHR-regulated genes has increased for estimating HAH concentrations in environmental media, for example, US EPA Method 4425 (Hu et al, 1995;Giesy et al, 1997;Pauwels et al, 2000;US EPA, 2000;Koppen et al, 2001;Covaci et al, 2002;Denison et al, 2004). A commonly used commercially available cell bioassay is the chemical-activated luciferase gene expression (CALUX) bioassay that measures the ability of a chemical mixture to activate AHR-dependent gene expression of the firefly luciferase gene in genetically modified cell lines relative to activation by TCDD (Aarts et al, 1995;Garrison et al, 1996;Murk et al, 1996).…”
Section: Introductionmentioning
confidence: 99%
“…A commonly used commercially available cell bioassay is the chemical-activated luciferase gene expression (CALUX) bioassay that measures the ability of a chemical mixture to activate AHR-dependent gene expression of the firefly luciferase gene in genetically modified cell lines relative to activation by TCDD (Aarts et al, 1995;Garrison et al, 1996;Murk et al, 1996). The CALUX bioassay typically utilizes an immortalized hepatomaderived cell line either from rats or mice (Murk et al, 1996;Denison et al, 2004). The results from the CALUX bioassay are often reported in TCDD equivalencies (TEQs) and compared against analytical TEQs determined for the mixture using GC-MS mass data and HAH congener-specific toxicity equivalency factors (TEFs; van den Berg et al, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…The CALUX method has been explained by various authors (Denison et al, 2004(Denison et al, , 2002Murk, 1996;). It uses genetically modified cells (hepatoma cells stably transfected with a luciferase reporter gene) which respond to chemicals that activate the cytosolar AhR by induction of luciferase (Denison et al, 2004).…”
mentioning
confidence: 99%
“…It uses genetically modified cells (hepatoma cells stably transfected with a luciferase reporter gene) which respond to chemicals that activate the cytosolar AhR by induction of luciferase (Denison et al, 2004). By this method, the toxicity of pollutants such as PCDD/Fs and dioxin like-PCBs is produced either as a change in gene expression mediated through the AhR or by interference with other pathways (Hurst, Balaam, Chan-Man, Thain, & Thomas, 2004).…”
mentioning
confidence: 99%